Literature DB >> 2961687

Correlates of plasma atrial natriuretic factor in health and hypertension.

P Montorsi1, G Tonolo, J Polonia, D Hepburn, A M Richards.   

Abstract

Plasma concentrations of atrial natriuretic factor (ANF) were compared in normotensive subjects and subjects with untreated, uncomplicated essential hypertension (n = 21 pairs) matched for age, sex, and race. Plasma peptide values were slightly greater (45 +/- 3 vs 36 +/- 3 pg/ml; p less than 0.05) in the hypertensive group. On univariate analysis, age (r = 0.52, n = 47, p less than 0.001) and creatinine clearance (r = -0.30, n = 47, p less than 0.05) were significantly related to plasma ANF concentrations, but arterial pressure was not (r = 0.14, n = 47), in an extended group of normal subjects. In contrast, plasma ANF values were related to arterial pressure in both an extended group of subjects with untreated essential hypertension (r = 0.54, n = 38, p less than 0.001) and in our total heterogeneous pool of hypertensive patients (r = 0.46, n = 79, p less than 0.001), but weak positive associations with age and inverse relationships with creatinine clearance were not statistically significant in either hypertensive group. Similar weak inverse relationships between plasma ANF values and renin-angiotensin-aldosterone system activity were found in both normal and hypertensive subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961687     DOI: 10.1161/01.hyp.10.6.570

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Brain natriuretic hormone predicts stress-induced alterations in diastolic function.

Authors:  Pratik Choksy; Harry C Davis; James Januzzi; Julian Thayer; Gregory Harshfield; Vincent J B Robinson; Gaston K Kapuku
Journal:  Am J Med Sci       Date:  2014-11       Impact factor: 2.378

2.  Plasma concentrations of brain natriuretic peptide: will this new test reduce the need for cardiac investigations?

Authors:  A D Struthers
Journal:  Br Heart J       Date:  1993-11

3.  [Effect of a beta 1-receptor blocker on the plasma level of atrial natriuretic peptide in patients with essential hypertension in the exercise test].

Authors:  J Plum; M Hollenbeck; P Heering; B Grabensee
Journal:  Klin Wochenschr       Date:  1990-05-04

Review 4.  B-type natriuretic Peptide and the right heart.

Authors:  Lok Bin Yap
Journal:  Heart Fail Rev       Date:  2004-04       Impact factor: 4.214

5.  Plasma concentration of atrial natriuretic factor in idiopathic oedema.

Authors:  T Nakada; J Shimazaki; S Isaka; H Fuse; H Sumiya; T Nishikawa; A Kumagai; H Furuta; T Katayama
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

6.  Role of atrial natriuretic peptide in the development of arterial hypertension in patients with pubertal hypothalamic syndrome.

Authors:  T P Krivchenko; N I Verbovaya
Journal:  Neurosci Behav Physiol       Date:  1998 Jul-Aug

7.  [Increased atrial natriuretic peptide in essential hypertension--relation to right atrial pressure behavior].

Authors:  L Neyses; J Nitsch; H P Tüttenberg; H C Korus; B Lüderitz
Journal:  Klin Wochenschr       Date:  1989-08-01

8.  Association of plasma B-type natriuretic peptide concentrations with longitudinal blood pressure tracking in African Americans: findings from the Jackson Heart Study.

Authors:  Ervin R Fox; Solomon K Musani; Preeti Singh; Aurelian Bidulescu; Harsha S Nagarajarao; Tandaw E Samdarshi; Michael W Steffes; Thomas J Wang; Herman A Taylor; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-11-26       Impact factor: 10.190

9.  Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.

Authors:  R de Châtel; J Makó; M Tóth; I Barna; R E Lang
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

10.  Discovering a new role for the atrial natriuretic peptide: A novel risk factor for cardiovascular diseases.

Authors:  Speranza Rubattu; Massimo Volpe
Journal:  Heart Int       Date:  2006-09-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.